Taking Vascepa, a prescription medication for high triglycerides, with blood thinners can increase the risk of bleeding due to their combined effects on blood clotting.
Vascepa has a warning label advising caution when concurrently taking anticoagulants or antiplatelet agents, which include blood thinners, due to the risk of bleeding [1]. Blood thinners work by inhibiting the body's natural clotting mechanisms, making it more difficult for wounds to heal and increasing the likelihood of excessive bleeding.
According to the Vascepa package insert, the potential for bleeding is of particular concern when the drug is taken concurrently with anticoagulants like warfarin, dabigatran, apixaban, or rivaroxaban, as well as antiplatelet medications such as aspirin or clopidogrel [2].
In order to minimize the risk, patients should inform their healthcare providers about any medications they are taking, including blood thinners [3]. Healthcare providers can then weigh the benefits and risks of taking Vascepa with blood thinners on an individual basis and provide guidance on managing the potential side effects.
For those who need to take both Vascepa and blood thinners, regular monitoring of the INR (International Normalized Ratio) value may be necessary to ensure that blood clotting remains within a safe range [4]. Regular check-ups with a healthcare provider are also crucial to identify any signs of bleeding or changes in blood clotting [5].
It's worth noting that drug interactions with Vascepa and blood thinners can vary depending on the specific medications involved. Therefore, patients should consult their healthcare provider for personalized guidance on safe use of both medications [6]. For a comprehensive list of potential interactions and precautions, visit the National Institute of Health's website or the website of the drug manufacturer, Amarin Pharmaceuticals [7].
Sources:
[1] Vascepa (icosapent ethyl) Package Insert. Amarin Pharmaceuticals. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022478s000lbl.pdf
[2] Blood Thinner Pills: Your Guide to Using Them Safely. (2018) American Heart Association. Retrieved from https://www.heart.org/en/healthy-living/heart-360/blood-thinner-pills
[3] Warfarin and Other Anticoagulants. (2022) Mayo Clinic. Retrieved from https://www.mayoclinic.org/drugs-supplements/warfarin-and-other-anticoagulants/safety/hrb-20059723
[4] INR Levels. (2020) National Institute of Health. Retrieved from https://www.nia.nih.gov/health/inr-levels
[5] Monitoring and Testing. (2022) National Heart, Lung, and Blood Institute. Retrieved from https://www.nhlbi.nih.gov/files/docs/public/heart/blood-thinners.pdf
[6] Drug Interactions. (2022) World Health Organization. Retrieved from https://www.who.int/news-room/questions-and-answers/detail/drug-interactions
[7] DrugPatentWatch.com: Vascepa. (2023) DrugPatentWatch. Retrieved from https://drugs-patent-watch.com/compound/vascepa